PMID: 11907521Mar 22, 2002Paper

Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study

Journal of the American Academy of Dermatology
M HeckmannG Plewig

Abstract

Recalcitrant pruritus is a hallmark of lichen simplex, a localized variant of atopic dermatitis. Acetylcholine has been demonstrated to mediate pruritus in atopic dermatitis. This open pilot study was done to determine the therapeutic effect of blocking acetylcholine release with botulinum toxin A in highly pruritic lichen simplex. Botulinum toxin A (Dysport) was injected intradermally into 5 circumscribed lichenoid lesions in 3 patients suffering from recalcitrant pruritus. No corticosteroids or any other specific topical therapy was administered. Pruritus subsided within 3 to 7 days in all 3 patients. Within 2 to 4 weeks all lesions cleared completely. No recurrences were noted over a 4-month follow-up. In one patient lichen simplex developed on the contralateral shin, which responded equally to a subsequent injection. We concluded that lichen simplex-associated pruritus can be overcome by intradermal botulinum toxin A injection. Acetylcholine appears to be a dominant pruritic mediator in this condition.

Citations

Nov 22, 2005·Dermatologic Therapy·Jana Hercogová
Jan 12, 2011·The British Journal of Dermatology·H L Tey, G Yosipovitch
Mar 7, 2012·The Journal of Dermatological Treatment·Ting-Shun Wang, Tsen-Fang Tsai
Mar 29, 2003·Current Allergy and Asthma Reports·Chih-Feng Tai, James N Baraniuk
Dec 16, 2006·Journal of Cosmetic Dermatology·Uwe WollinaSven Petersen
Feb 22, 2011·Journal of Cosmetic Dermatology·Amir FeilyHossein Kalantar
Apr 27, 2010·Dermatologic Therapy·Gulsum GencoglanKamer Gunduz
Mar 30, 2010·The British Journal of Dermatology·J Wallengren, J Bartosik
Aug 24, 2013·International Journal of Dermatology·Emad GeddoaTrevor Rudrah Franco Paes
Dec 3, 2015·Expert Opinion on Pharmacotherapy·Carolyn StullGil Yosipovitch
Apr 27, 2017·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Sang Bum HanHei Sung Kim
Dec 21, 2017·Toxins·Yoon Seob KimHei Sung Kim
Jun 20, 2018·International Journal of Dermatology·Mohammad Jafferany, Maryam E Davari
Mar 30, 2018·Toxins·Parisa Gazerani
Jan 26, 2020·The Cochrane Database of Systematic Reviews·Andrea AndradeJuan Va Franco
Jul 12, 2020·American Journal of Clinical Dermatology·Tina S Alster, Iris S Harrison
Oct 7, 2008·Clinical Neuropharmacology·Arash SalardiniBahman Jabbari
Jul 25, 2009·The British Journal of Dermatology·P GazeraniL Arendt-Nielsen
Jul 17, 2016·Journal of the European Academy of Dermatology and Venereology : JEADV·E ForbatF Al-Niaimi
Apr 16, 2020·The Journal of Dermatology·Aisha IsmailCarmen Farid
Nov 16, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Sonja StänderDieter Metze

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Related Papers

The Journal of Dermatological Treatment
Roland Aschoff, Gottfried Wozel
Therapeutics and Clinical Risk Management
Sonja StänderElke Weisshaar
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
D M CohenC E Tomich
Nurse Practitioner Forum
N H Nicol, M Boguniewicz
The Journal of Dermatological Treatment
Mohammad Hassan JavanbakhtAbbas Mirshafiey
© 2022 Meta ULC. All rights reserved